Meet
Dr.Zara
Bagdasarian
Founder, CEO
“The doctor of the future will interest patients to Repair, Renew and Reset their body to its natural self-healing state to prevent and Recover from illnesses. The process will Repeatedly tailored to individual genetics, lifestyle, and environment.”
About
Dr. Zara Bagdasarian embodies the evolution in healthcare, merging three generations of family medical tradition with extensive experience in health and wellness practices. In 2020, during a pivotal moment in healthcare history, she founded Really Good Remedies to bridge the critical gap between conventional treatments and wellness care, redefining what real healthcare must be.
Trained and certified at Harvard Medical School in Lifestyle Medicine, she specializes in Functional Medicine, Applied Clinical Nutrition, Medicinal Herbal, and Homeopathic Therapies. She holds a Bachelor of Science degree in Biology and Biochemistry, as well as a Doctor of Chiropractic degree from Life Chiropractic College West. She was honored with an award for excellence in Applied Clinical Nutrition from Texas Chiropractic College.
Her approach focuses on optimizing cellular health by addressing inflammation, detoxification pathways, methylation processes, and oxidative stress, enabling patients to make targeted lifestyle changes that support, prevent, and reverse chronic health challenges, including metabolic syndrome, cholesterol and blood sugar dysregulation, cardiovascular issues, hypertension, hormonal imbalances, mood disorders, cognitive decline, weight management issues, and athletic performance.
Trusted by Champions Elite Athletes, including San Francisco 49ers, professional soccer players, and champion golfers, rely on Dr. Zara as their trusted wellness advisor. Her evidence-based protocols optimize recovery, prevent injury, and sustain peak performance throughout the most demanding seasons. Complementing her customized wellness programs, her innovative NeuroBalancing Orthotics™ provides the crucial stability foundation that separates champions from competitors.
As an Executive Wellness Pioneer, understanding that business leaders face performance demands comparable to elite athletes, Dr. Zara has developed specialized wellness programs for Silicon Valley executives and high-achieving professionals. Her innovative 'corporate athlete' approach targets stress management, cognitive optimization, and performance improvement. Just as athletes need peak physical condition for competition, executives need optimal health and mental clarity to excel in today's demanding business environment.
Global Impact of Wellness – Dr. Zara has spoken internationally, presenting her expertise at medical conferences alongside distinguished scientists and researchers from around the world. She regularly mentors healthcare providers in advanced functional medicine protocols and has been featured at prestigious medical events with leading industry experts. Her contributions in health and wellness have impacted many lives across the globe as she provides her patients with access to advanced health and wellness services.
Leo Bagdasarian, Chief Operating Officer
Leo Bagdasarian is a Co-Founder and Chief Operating Officer of Really Good Remedies. He leads operational strategy, execution, and organizational growth, where he leverages his unique blend of financial expertise and operational excellence to advance personalized health and wellness. Drawing from a diverse background spanning economics, accounting, agriculture, venture debt, strategic consulting, and community organization. Leo combines analytical rigor with hand-on operations. His experience working for a UHNW family office, in agriculture, and grassroots community organizing has shaped his approach to operations and management: rigorous in analysis, collaborative in execution, and always focused on outcomes. Guided by a personal dedication to health and wellness, Leo focuses on creating lasting value for Really Good Remedies, its patients, and the broader community through thoughtful leadership that supports long-term success.
Advisory Board
Dr. Rouben Aroutiounian, PhD
Dr. Rouben Aroutiounian is Secretary of Natural Sciences National Academy of Science and Member of the Presidium of National Academy of Science Republic of Armenia. He is a distinguished geneticist, Professor, and Head of the Department of Genetics and Cytology at Yerevan State University, where he also directs the Laboratory of General and Molecular Genetics. His landmark doctoral research explored the mechanisms of antimutagens in protecting human cells against chemical mutagens, laying foundational insights for modern cellular resilience and environmental toxicology. Dr. Aroutiounian has dedicated his career to understanding how human DNA interacts with its environment. With over five decades of research and academic leadership, his core expertise spans mutagenesis, molecular cytogenetics, ecological genetics, and eco-toxicological genetics, providing invaluable, data-driven insights into how cellular mechanisms protect themselves and recover from external environmental stressors. Notably, his foundational doctoral research focused heavily on the mechanisms of antimutagens and how they mitigate the damaging effects of chemical mutagens in human cells—laying the essential groundwork for modern preventative and protective gene-based medicine. Throughout his career, he has published extensive research evaluating DNA damage and repair kinetics, the genotoxic impact of environmental toxins like mycotoxins, and cellular resilience. Currently, Dr. Aroutiounian leads vital research initiatives utilizing diverse test systems to evaluate mutagenic environmental pollutants and monitor their ongoing impact on public health. For the past five years, he has directed a major scientific project investigating genomic instability in COVID-19 patients. Dr. Aroutiounian is the author of extensive literature and research on DNA damage and repair kinetics. He has published more than 300 papers as well as two monographs, two textbooks, and 12 encyclopedic chapters. Notably, his monograph with Prof. Erich Gebhart, Anticlastogens in Mammalian and Human Cells (Springer-Verlag), is dedicated to chromosome protection against chemical mutagens using antimutagenic substances. Globally recognized for his contributions to genomic stability, Dr. Aroutiounian has served on the Scientific Committee of the International Barcode Life Consortium and as Chairman of the National Scientific Council on Natural Property. He is a multilingual leader fluent in English, Russian, Armenian, French, and German, who has actively shaped international scientific governance. Dr. Aroutiounian’s honors are recognized globally for his monumental contributions, his accolades include the 2022 Anniversary Medal of the International Association of Academies of Sciences reinforcing his status as a world-class visionary in cellular preservation.
Dr. George Mutafyan, MD
Dr. George Mutafyan is an award-winning, board-certified general surgeon with more than two decades of surgical experience, specializing in complex metabolic diseases including weight management, and advanced gastrointestinal care. He completed his fellowship training in minimally invasive, general, and bariatric surgery at Duke University Medical Center. With experience in more than 800 surgical cases, Dr. Mutafyan has extensive expertise in gastrointestinal and abdominal surgery, complex general surgical care, and minimally invasive techniques. His high-volume clinical practice serves more than 400 new patients annually with gastrointestinal concerns, providing comprehensive, patient-centered care that extends well beyond the operating room. His professional work also spans surgical innovation, medical-device development, clinical research, humanitarian medicine, and public medical education. As a physician-inventor, Dr. Mutafyan has developed proprietary surgical technologies designed to address significant unmet needs in advanced electrosurgery and the operative management of complex solid-organ injuries. Dr. Mutafyan is also the founder of the Armenian American Medical Mission and an author, reflecting his enduring commitment to advancing surgical care, health and wellness education, and humanitarian service.
Stan Stukov BS-EECS, MSCS
Stan Stukov is an accomplished technology executive, inventor, and bioinformatics pioneer with over three decades of leadership across genomics, enterprise AI, and software engineering. He played a foundational role in the emergence of modern transcriptomics as a founding team member and Head of Software Development at Synteni, Inc. Founded in 1994, Synteni was the first commercial company built around spotted cDNA gene-expression microarrays, commercializing the technology developed at Patrick Brown’s Stanford University. Stan spearheaded the software architecture for the Gene Expression Microarray (GEM) platform. This breakthrough enabled the parallel, quantitative measurement of thousands of active genes simultaneously, shifting biological research to analyzing whole-genome expression patterns and established the foundation for modern transcriptomics, disease classification, and pharmacogenomics. Following Synteni’s acquisition Stan served as Vice President of Informatics, managing bioinformatics databases and analytical tools as the company scaled its platform to cover roughly 60,000 human genes. Beyond his pioneering work in life sciences, Stan has scaled high-growth enterprise software and logistics companies. He has an extensive background holding core leadership and engineering management roles at Intel, Microsoft, Rubic, Enkata Technologies and Fujitsu. He currently serves as CEO of ePeople AI, developing AI-driven operational solutions for healthcare, and as President and CEO of VinTelligent, Inc., overseeing a logistics platform connecting global automotive manufacturers. Previously, he served as President and CTO at Enkata Technologies prior to its acquisition by Pegasystems, and as Vice President of Engineering at Rubric, culminating in a $480 million acquisition by Broadbase Software. Drawing on his foundational experience in gene-expression analysis, [Name] is passionate about applying a data-driven approach to modern wellness. He believes the future of proactive health lies at the intersection of personalized biology, science-backed nutrition, and emerging technologies. Drawing on his experience in gene-expression analysis and molecular biology, Stan is passionate about applying a data-driven approach to modern wellness. He believes the future of proactive health lies at the intersection of personalized biology, science-backed nutrition, and emerging technologies.